Samantha Macro, PhD MCA MBA

Samantha has a distinguished career in finance leadership across some of the most recognised names in biotechnology. As well as Centauri, she is also fractional CFO for StemSight and Broken String Biosciences. Previously she served as CFO at CN-BIO she played a key role at Mestag Therapeutics, where she helped secure a $45 million seed financing round.

Her background also includes senior positions at Horizon Discovery, Johnson Matthey Pharma, Cambridge Antibody Technology, MedImmune, and AstraZeneca—where she supported strategic growth, M&A initiatives, and major fundraising efforts across the life sciences sector.